Cargando…
Metformin and cancer hallmarks: shedding new lights on therapeutic repurposing
Metformin is a well-known anti-diabetic drug that has been repurposed for several emerging applications, including as an anti-cancer agent. It boasts the distinct advantages of an excellent safety and tolerability profile and high cost-effectiveness at less than one US dollar per daily dose. Epidemi...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286395/ https://www.ncbi.nlm.nih.gov/pubmed/37344841 http://dx.doi.org/10.1186/s12967-023-04263-8 |